Fractional flow reserve-guided PCI versus medical therapy in stable coronary disease.

@article{Bruyne2012FractionalFR,
  title={Fractional flow reserve-guided PCI versus medical therapy in stable coronary disease.},
  author={B. de Bruyne and N. Pijls and B. Kalesan and E. Barbato and Pim A. L. Tonino and Z. Pir{\'o}th and N. Jagic and S. M{\"o}bius-Winkler and G. Rioufol and N. Witt and P. Kala and P. MacCarthy and T. Engstroem and K. Oldroyd and Kreton Mavromatis and G. Manoharan and P. Verlee and O. Frobert and N. Curzen and J. E. Johnson and P. J{\"u}ni and W. Fearon},
  journal={The New England journal of medicine},
  year={2012},
  volume={367 11},
  pages={
          991-1001
        }
}
BACKGROUND The preferred initial treatment for patients with stable coronary artery disease is the best available medical therapy. We hypothesized that in patients with functionally significant stenoses, as determined by measurement of fractional flow reserve (FFR), percutaneous coronary intervention (PCI) plus the best available medical therapy would be superior to the best available medical therapy alone. METHODS In patients with stable coronary artery disease for whom PCI was being… Expand
1,748 Citations

Paper Mentions

Interventional Clinical Trial
The overall purpose of Flash FFR Ⅱ is to investigate whether coronary angiography-derived fractional flow reserve (caFFR), compared with fractional flow reserve (FFR) measured by a… Expand
ConditionsAcute Myocardial Infarction, Asymptomatic Ischemia, Coronary Artery Disease, (+6 more)
InterventionDiagnostic Test
Interventional Clinical Trial
The overall purpose of the FAVOR III China trial is to investigate if a strategy of quantitative flow ratio (QFR)-guided percutaneous coronary intervention (PCI) yields superior… Expand
ConditionsCoronary Artery Disease, Coronary Circulation, Coronary Stenosis, (+2 more)
InterventionDiagnostic Test
Observational Patient Registry Clinical Trial
A multicentre (5-8 sites), post-marketing, observational trial in 200 patients, whose standard diagnostic workup for chronic coronary syndromes provided for Invasive Coronary… Expand
ConditionsCoronary Artery Disease, Stable Ischemic Heart Disease
InterventionDevice, Procedure
Observational Clinical Trial
Data are limited regarding the optimal treatment of the non-culprit lesions (NCL) after myocardial infarction (MI). The NON-CULPRIT study is a prospective cohort study with a… Expand
ConditionsFractional Flow Reserve
InterventionProcedure
Fractional flow reserve-guided PCI for stable coronary artery disease.
  • 711
  • PDF
Five‐Year Outcomes with PCI Guided by Fractional Flow Reserve
  • 240
  • PDF
Is FAME 2 a breakthrough for PCI in stable coronary disease?
  • U. Sechtem
  • Medicine
  • Clinical Research in Cardiology
  • 2014
  • 8
  • PDF
...
1
2
3
4
5
...

References

SHOWING 1-10 OF 37 REFERENCES
Optimal medical therapy with or without PCI for stable coronary disease.
  • 2,804
  • PDF
Fractional flow reserve versus angiography for guiding percutaneous coronary intervention.
  • 2,066
  • PDF
...
1
2
3
4
...